Prime Medicine (PRME) Amortization - Intangibles (2023 - 2026)

Prime Medicine has reported Amortization - Intangibles for 4 years, with the latest figure at $460000.0 in Q1 2026.

• For the quarter ending Q1 2026, Amortization - Intangibles rose 35.69% year-over-year to $460000.0; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (down 13.79% YoY), and the FY2025 full-year result was $2.5 million, down 29.31% from the prior year.
• Amortization - Intangibles for Q1 2026 stood at $460000.0, down from $858000.0 in the prior quarter.
• The five-year high for Amortization - Intangibles was $2.0 million in Q2 2023, with the low at $306000.0 in Q4 2024.
• Historically, Amortization - Intangibles has averaged $942083.3 across 4 years, with a median of $844000.0 in 2024.
• Annual changes were most pronounced in 2024 — Amortization - Intangibles plunged 72.82% — and 2025, when it surged 180.39%.
• Prime Medicine's Amortization - Intangibles stood at $1.1 million in 2023, then sank by 72.82% to $306000.0 in 2024, then soared by 180.39% to $858000.0 in 2025, then plunged by 46.39% to $460000.0 in 2026.
• The last three Amortization - Intangibles figures came in at $460000.0 (Q1 2026), $858000.0 (Q4 2025), and $752000.0 (Q3 2025), per Business Quant data.